ХІМІОТЕРАПІЯ РАКУ ШЛУНКА. МЕТААНАЛІЗИ
DOI:
https://doi.org/10.24061/1727-4338.XIII.3.49.2014.31Ключові слова:
рак, шлунок, хіміотерапія, метааналізАнотація
Резюме. Представлений огляд метааналізів із хіміотерапії раку шлунка. Паліативна хіміотерапія продовжує життя хворих на кілька місяців. Роль нео- та ад'ювантної хіміотерапії неоднозначна. Хіміотерапевтичне лікування раку шлунка рекомендується до клінічного застосування і подальшого вивчення.
Посилання
Ge L, Wang HJ, Yin D, Lei C, Zhu JF, Cai XH, et al. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis. World J Gastroenterol. 2012 Dec 28; 18(48): 7384–7393. doi: 10.3748/wjg.v18.i48.7384.
Hsu C1, Shen YC, Cheng CC, Cheng AL, Hu FC, Yeh KH. Geographic difference in safety and efficacy of systemicchemotherapy for advanced gastric or gastroesophagealcarcinoma: a meta-analysis and meta-regression. Gastric Cancer. 2012 Jul;15(3):265-80. doi: 10.1007/s10120-012-0151-8.
Knight G, Earle CC, Cosby R, Coburn N, Youssef Y, Malthaner R, et al. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. Gastric Cancer. 2013 Jan;16(1):28-40. doi: 10.1007/s10120-012-0148-3.
Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gasric cancer: a meta analysis. World J Gastroenterol. 2010 Nov 28;16(44):5621-8.
Liao Y, Yang ZL, Peng JS, Xiang J, Wang JP. Liao Neoadjuvant Chemotherapy for Gastric Cancer A Meta-analysis of Randomized, Controlled Trials. J Gastroenterol Hepatol. 2013 May;28(5):777-82. doi: 10.1111/jgh.12152.
Mackenzie M, Spithoff K, Jonker D. Systemic therapy for advanced gastric cancer: a clinical practice guideline. Curr Oncol. 2011 Aug;18(4):e202-9.
Mackenzie M, Spithoff K, Jonker D. Systemic therapy for advanced gastric cancer: a clinical practice guideline. Evidence-based series 2-26 in review. [Internet]. [cited 2013 Dec 24]; 2013;28(5):777-82. Available from: www.cancercare.on.ca.
Markar SR, Karthikesalingam A, Jackson D, Hanna GB. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East. Ann Surg Oncol. 2013 Jul;20(7):2328-38. doi: 10.1245/s10434-012-2862-9.
Min C, Bangalore S, Jhawar S, Guo Y, Nicholson J, Formenti SC, et al. Chemoradiation Therapy versus Chemotherapy Alone for Gastric Cancer after R0 Surgical Resection: A Meta-Analysis of Randomized Trials. Oncology. 2014;86(2):79-85. doi: 10.1159/000354641.
GASTRIC Group, Oba K, Paoletti X, Bang YJ, Bleiberg H, Burzykowski T, et al. Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer. 2013 May;49(7):1565-77. doi: 10.1016/j.ejca.2012.12.016.
Quéro L, Guillerm S, Hennequin C. Neoadjuvant or adjuvant therapy for respectable gastric cancer. World J Gastrointest Oncol. 2015 Aug 15;7(8):102-10. doi: 10.4251/wjgo.v7.i8.102.
GASTRIC Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010 May 5;303(17):1729-37. doi: 10.1001/jama.2010.534.
Qi WX, Shen Z, Lin F, Sun YJ, Min DL, Tang LN, et al. Overall survival benefits for irinotecan-containing regimens as first-line treatment for advanced gastric cancer: an updated meta-analysis of ten randomized controlled trials. Int J Cancer. 2013 Jan 15;132(2):E66-73. doi: 10.1002/ijc.27775.
Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, et al. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. Eur J Cancer. 2013 Oct;49(15):3149-58. doi: 10.1016/j.ejca.2013.05.029.
GASTRIC Group, Oba K, Paoletti X, Bang YJ, Bleiberg H, Burzykowski T, et al. Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis. Eur J Cancer. 2013 May;49(7):1565-77. doi: 10.1016/j.ejca.2012.12.016.
Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD004064. doi: 10.1002/14651858.CD004064.pub3.
Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for locally advanced gastric cancer: a Meta analysis. World J Gastroenterol. 2010 Nov 28;16(44):5621-8.
Wu AW, Xu GW, Wang HY, Ji JF, Tang JL. Neoadjuvant chemotherapy none for resectable gastric cancer. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005047. doi: 10.1002/14651858.CD005047.pub2.
Xia GG, Zhang CH, Wei ZW, Wu Y, He YL. [Meta-analysis of adjuvant chemotherapy on prognosis for gastric cancer patients after D2 dissection]. Zhonghua Wai Ke Za Zhi. 2013 May 1;51(5):447-51.
Zhang CD, Zeng YJ, Li HW, Zhao ZM, Zhang JK, Dai DQ. Neoadjuvant chemotherapy for nonmetastatic esophago-gastric adenocarcenomas: a systematic review and meta-analysis. Cancer Invest. 2013 Jul;31(6):421-31. doi: 10.3109/07357907.2013.802801.
Zhang YW, Zhang YL, Pan H, Wei FX, Zhang YC, Shao Y, et al. Chemotherpy for patients with gastric cancer after complete resection: A network meta-analysis. World J Gastroenterol. 2014 Jan 14;20(2):584-92. doi: 10.3748/wjg.v20.i2.584.
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2018 R. V. Senyutovich, O. I. Ivashchuk, K. V. Barannikow, V. M. Pylypiv, R. V. Senyutovich, V. Y. Bodyaka, O. V. Cnornuy
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Часопис користується «Типовим шаблоном положення про авторські права».
